Matches in SemOpenAlex for { <https://semopenalex.org/work/W2662488897> ?p ?o ?g. }
- W2662488897 endingPage "2555" @default.
- W2662488897 startingPage "2534" @default.
- W2662488897 abstract "Peripheral artery disease affects >200 million people worldwide and is associated with significant limb and cardiovascular morbidity and mortality. Limb revascularization is recommended to improve function and quality of life for symptomatic patients with peripheral artery disease with intermittent claudication who have not responded to medical treatment. For patients with critical limb ischemia, the goals of revascularization are to relieve pain, help wound healing, and prevent limb loss. The baseline risk of cardiovascular and limb-related events demonstrated among patients with stable peripheral artery disease is elevated after revascularization and related to atherothrombosis and restenosis. Both of these processes involve platelet activation and the coagulation cascade, forming the basis for the use of antiplatelet and anticoagulant therapies to optimize procedural success and reduce postprocedural cardiovascular risk. Unfortunately, few high-quality, randomized data to support use of these therapies after peripheral artery disease revascularization exist, and much of the rationale for the use of antiplatelet agents after endovascular peripheral revascularization is extrapolated from percutaneous coronary intervention literature. Consequently, guideline recommendations for antithrombotic therapy after lower limb revascularization are inconsistent and not always evidence-based. In this context, the purpose of this structured review is to assess the available randomized data for antithrombotic therapy after peripheral arterial revascularization, with a focus on clinical trial design issues that may affect interpretation of study results, and highlight areas that require further investigation." @default.
- W2662488897 created "2017-06-30" @default.
- W2662488897 creator A5025877024 @default.
- W2662488897 creator A5032937627 @default.
- W2662488897 creator A5037362475 @default.
- W2662488897 creator A5038722538 @default.
- W2662488897 creator A5038981448 @default.
- W2662488897 creator A5049378858 @default.
- W2662488897 creator A5054781690 @default.
- W2662488897 creator A5059462706 @default.
- W2662488897 creator A5065985671 @default.
- W2662488897 creator A5076746946 @default.
- W2662488897 creator A5083044150 @default.
- W2662488897 date "2017-06-20" @default.
- W2662488897 modified "2023-10-14" @default.
- W2662488897 title "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization" @default.
- W2662488897 cites W146673325 @default.
- W2662488897 cites W1485191699 @default.
- W2662488897 cites W1606473227 @default.
- W2662488897 cites W1944762875 @default.
- W2662488897 cites W194894827 @default.
- W2662488897 cites W1967683868 @default.
- W2662488897 cites W1969530606 @default.
- W2662488897 cites W1970419820 @default.
- W2662488897 cites W1970546724 @default.
- W2662488897 cites W1974655135 @default.
- W2662488897 cites W1975326506 @default.
- W2662488897 cites W1980404286 @default.
- W2662488897 cites W1984684769 @default.
- W2662488897 cites W1988719433 @default.
- W2662488897 cites W1996874952 @default.
- W2662488897 cites W1998420251 @default.
- W2662488897 cites W2003103658 @default.
- W2662488897 cites W2006645843 @default.
- W2662488897 cites W2007069182 @default.
- W2662488897 cites W2014336636 @default.
- W2662488897 cites W2016596948 @default.
- W2662488897 cites W2024352468 @default.
- W2662488897 cites W2026287153 @default.
- W2662488897 cites W2029445392 @default.
- W2662488897 cites W2033924621 @default.
- W2662488897 cites W2034942998 @default.
- W2662488897 cites W2035620169 @default.
- W2662488897 cites W2037500444 @default.
- W2662488897 cites W2037994129 @default.
- W2662488897 cites W2044658006 @default.
- W2662488897 cites W2058217708 @default.
- W2662488897 cites W2059871922 @default.
- W2662488897 cites W2059885795 @default.
- W2662488897 cites W2060582931 @default.
- W2662488897 cites W2078043377 @default.
- W2662488897 cites W2078178450 @default.
- W2662488897 cites W2078349288 @default.
- W2662488897 cites W2079595856 @default.
- W2662488897 cites W2081458532 @default.
- W2662488897 cites W2087242360 @default.
- W2662488897 cites W2087541472 @default.
- W2662488897 cites W2089150123 @default.
- W2662488897 cites W2090947041 @default.
- W2662488897 cites W2093365874 @default.
- W2662488897 cites W2097854437 @default.
- W2662488897 cites W2098413228 @default.
- W2662488897 cites W2100089051 @default.
- W2662488897 cites W2100209149 @default.
- W2662488897 cites W2106174706 @default.
- W2662488897 cites W2110101054 @default.
- W2662488897 cites W2111260323 @default.
- W2662488897 cites W2113645730 @default.
- W2662488897 cites W2115772984 @default.
- W2662488897 cites W2117559770 @default.
- W2662488897 cites W2122779695 @default.
- W2662488897 cites W2123874951 @default.
- W2662488897 cites W2129363077 @default.
- W2662488897 cites W2133752587 @default.
- W2662488897 cites W2134322421 @default.
- W2662488897 cites W2140501627 @default.
- W2662488897 cites W2140939280 @default.
- W2662488897 cites W2141358924 @default.
- W2662488897 cites W2142021807 @default.
- W2662488897 cites W2147746835 @default.
- W2662488897 cites W2148374679 @default.
- W2662488897 cites W2153281494 @default.
- W2662488897 cites W2159701798 @default.
- W2662488897 cites W2163892770 @default.
- W2662488897 cites W2164915878 @default.
- W2662488897 cites W2165349656 @default.
- W2662488897 cites W2237104093 @default.
- W2662488897 cites W2284223850 @default.
- W2662488897 cites W2295484744 @default.
- W2662488897 cites W2295508527 @default.
- W2662488897 cites W2314922794 @default.
- W2662488897 cites W2344189478 @default.
- W2662488897 cites W2404680446 @default.
- W2662488897 cites W2415983038 @default.
- W2662488897 cites W2430015321 @default.
- W2662488897 cites W2467504996 @default.
- W2662488897 cites W2556414715 @default.
- W2662488897 cites W2556919357 @default.